UniProt ID | NTPCR_HUMAN | |
---|---|---|
UniProt AC | Q9BSD7 | |
Protein Name | Cancer-related nucleoside-triphosphatase | |
Gene Name | NTPCR | |
Organism | Homo sapiens (Human). | |
Sequence Length | 190 | |
Subcellular Localization | ||
Protein Description | Has nucleotide phosphatase activity towards ATP, GTP, CTP, TTP and UTP. Hydrolyzes nucleoside diphosphates with lower efficiency.. | |
Protein Sequence | MARHVFLTGPPGVGKTTLIHKASEVLKSSGVPVDGFYTEEVRQGGRRIGFDVVTLSGTRGPLSRVGLEPPPGKRECRVGQYVVDLTSFEQLALPVLRNADCSSGPGQRVCVIDEIGKMELFSQLFIQAVRQTLSTPGTIILGTIPVPKGKPLALVEEIRNRKDVKVFNVTKENRNHLLPDIVTCVQSSRK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MARHVFLTG ------CCCEEEECC | 15.41 | 19413330 | |
8 | Phosphorylation | MARHVFLTGPPGVGK CCCEEEECCCCCCCH | 35.86 | 23532336 | |
15 | Acetylation | TGPPGVGKTTLIHKA CCCCCCCHHHHHHHH | 35.61 | 25953088 | |
15 | Ubiquitination | TGPPGVGKTTLIHKA CCCCCCCHHHHHHHH | 35.61 | - | |
21 | Acetylation | GKTTLIHKASEVLKS CHHHHHHHHHHHHHH | 46.76 | 19608861 | |
21 | Ubiquitination | GKTTLIHKASEVLKS CHHHHHHHHHHHHHH | 46.76 | 21890473 | |
27 | Ubiquitination | HKASEVLKSSGVPVD HHHHHHHHHCCCCCC | 47.99 | - | |
37 | Phosphorylation | GVPVDGFYTEEVRQG CCCCCCEEHHHHHCC | 20.83 | 28796482 | |
38 | Phosphorylation | VPVDGFYTEEVRQGG CCCCCEEHHHHHCCC | 24.33 | 28796482 | |
54 | Phosphorylation | RIGFDVVTLSGTRGP EEEEEEEEECCCCCC | 18.30 | 20068231 | |
56 | Phosphorylation | GFDVVTLSGTRGPLS EEEEEEECCCCCCHH | 28.84 | 20068231 | |
58 | Phosphorylation | DVVTLSGTRGPLSRV EEEEECCCCCCHHHC | 29.13 | 20068231 | |
73 | Acetylation | GLEPPPGKRECRVGQ CCCCCCCCCCCCCCC | 51.28 | 25953088 | |
73 | Ubiquitination | GLEPPPGKRECRVGQ CCCCCCCCCCCCCCC | 51.28 | - | |
102 | Phosphorylation | VLRNADCSSGPGQRV HHHCCCCCCCCCCEE | 38.59 | 21406692 | |
103 | Phosphorylation | LRNADCSSGPGQRVC HHCCCCCCCCCCEEE | 56.17 | 21406692 | |
135 | Phosphorylation | AVRQTLSTPGTIILG HHHHHCCCCCEEEEE | 28.93 | 24719451 | |
148 | Ubiquitination | LGTIPVPKGKPLALV EEEEECCCCCCCHHH | 78.70 | 21890473 | |
150 | Ubiquitination | TIPVPKGKPLALVEE EEECCCCCCCHHHHH | 42.88 | - | |
150 | Malonylation | TIPVPKGKPLALVEE EEECCCCCCCHHHHH | 42.88 | 26320211 | |
165 | Ubiquitination | IRNRKDVKVFNVTKE HHCCCCCEEEEECCC | 51.77 | 21890473 | |
165 | Acetylation | IRNRKDVKVFNVTKE HHCCCCCEEEEECCC | 51.77 | 19608861 | |
165 | Malonylation | IRNRKDVKVFNVTKE HHCCCCCEEEEECCC | 51.77 | 26320211 | |
170 | Phosphorylation | DVKVFNVTKENRNHL CCEEEEECCCCCCCC | 33.47 | - | |
171 | Acetylation | VKVFNVTKENRNHLL CEEEEECCCCCCCCC | 49.02 | 25953088 | |
171 | Ubiquitination | VKVFNVTKENRNHLL CEEEEECCCCCCCCC | 49.02 | 21890473 | |
171 | Malonylation | VKVFNVTKENRNHLL CEEEEECCCCCCCCC | 49.02 | 26320211 | |
184 | Glutathionylation | LLPDIVTCVQSSRK- CCHHHHHHHHHCCC- | 1.49 | 22555962 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NTPCR_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NTPCR_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NTPCR_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
STABP_HUMAN | STAMBP | physical | 21988832 | |
WDR19_HUMAN | WDR19 | physical | 27173435 | |
WDR35_HUMAN | WDR35 | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-21 AND LYS-165, AND MASSSPECTROMETRY. |